Phaxiam Statements
PH
Data from Phaxiam`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
31 Dec, 2023
Next reporting period:
28 Jun, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
13 Nov, 2024
Phaxiam Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
1.048
277 %
100
—
0
—
—
0
7.01
668.9
4.831
461
12.31
-2.9 %
1174.6
-11.262
9.2 %
-1074.6
-0.303
-28.9
0.277
26.4
-11.288
9 %
-1077.1
—
0
-11.287
7.5 %
-1077.004
-1.709
6.606
0.278
-95.1 %
100
—
0
—
—
0
3.28
1179.9
9.355
3365.1
12.676
47.7 %
4559.7
-12.398
-329.1 %
-4459.7
-0.034
-12.2
0.023
8.3
-12.409
-412.8 %
-4463.7
-0.208
-74.8
-12.201
-1632.8 %
-4388.8
-3.433
3.554
5.694
496.9 %
100
—
0
—
—
0
2.235
39.3
6.018
105.7
8.583
-66 %
150.7
-2.889
88.1 %
-50.7
0.469
8.2
—
0
-2.42
-189.2 %
-42.5
-3.216
-56.5
0.796
177.7 %
14
0.257
3.102
0.954
—
100
—
0
—
—
0
13.68
1434
7.242
759.1
25.212
—
2642.8
-24.258
—
-2542.8
2.604
273
0.016
1.7
2.713
—
284.4
3.737
391.7
-1.024
—
-107.3
-0.33
3.102